China Life Insurance Company Ltd (LFC) 10.23

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Life Insurance Company Ltd (LFC) 10.23 $LFC

Downtrend Call Working As China Life Insurance Stock Falls 20.4% (LFC)
Comtex SmarTrend(R) - Tue Jun 07, 12:43AM CDT
SmarTrend identified a Downtrend for China Life Insurance (NYSE:LFC) on January 11th, 2016 at $13.85. In approximately 5 months, China Life Insurance has returned 20.36% as of today's recent price of $11.03.
LFC: 10.23 (-0.50)

Shares of LFC Down 21.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri May 27, 1:52PM CDT
SmarTrend identified a Downtrend for China Life Insurance (NYSE:LFC) on January 11th, 2016 at $13.85. In approximately 5 months, China Life Insurance has returned 21.52% as of today's recent price of $10.87.
LFC: 10.23 (-0.50)

How These Life Insurance Stocks are Performing? - American Equity Investment Life Holding, China Life Insurance, Torchmark, and Prudential
PR Newswire - Tue May 24, 7:25AM CDT
Today, ActiveWallSt.com redirects investors' focus on these Life Insurance equities: American Equity Investment Life Holding Co. (NYSE: AEL), China Life Insurance Co. Ltd (NYSE: LFC), Torchmark Corp. (NYSE: TMK), and Prudential PLC (NYSE: PUK). To receive your free alerts on these stocks, click below:
TMK: 60.18 (-0.46), AEL: 15.62 (-0.33), LFC: 10.23 (-0.50), PUK: 34.94 (-0.55)

China Life Insurance Shares Down 23.8% Since SmarTrend's Sell Call (LFC)
Comtex SmarTrend(R) - Thu May 12, 1:35PM CDT
SmarTrend identified a Downtrend for China Life Insurance (NYSE:LFC) on January 11th, 2016 at $13.85. In approximately 4 months, China Life Insurance has returned 23.83% as of today's recent price of $10.55.
LFC: 10.23 (-0.50)

20.4% Return Seen to Date on SmarTrend China Life Insurance Call (LFC)
Comtex SmarTrend(R) - Thu May 05, 1:49PM CDT
SmarTrend identified a Downtrend for China Life Insurance (NYSE:LFC) on January 11th, 2016 at $13.85. In approximately 4 months, China Life Insurance has returned 20.43% as of today's recent price of $11.02.
LFC: 10.23 (-0.50)

China Life Announces Filing of 2015 Annual Report on Form 20-F
PR Newswire - Fri Apr 22, 6:35AM CDT
China Life Insurance Company Limited (the "Company" (NYSE: LFC; HKSE: 2628; SSE: 601628), announced that the Company has filed its 2015 Annual Report on Form 20-F (the "2015 Form 20-F", which includes its audited financial statements for the fiscal year ended December 31, 2015, with the United States Securities and Exchange Commission.
LFC: 10.23 (-0.50)

Downgrade Alert for China Life Insurance (LFC)
Comtex SmarTrend(R) - Wed Apr 20, 3:24AM CDT
China Life Insurance (NYSE:LFC) was downgraded from Buy to Neutral at UBS today. The stock closed yesterday at $12.68 on volume of 648,000 shares, below average daily volume of 1.1 million. In the past 52 weeks, China Life Insurance share prices have been bracketed by a low of $10.18 and a high of $77.97 and closed yesterday at $12.68, 25% above that low price. The 200-day and 50-day moving averages have moved 0.83% lower and 0.74% higher over the past week, respectively.
LFC: 10.23 (-0.50)

China Life Insurance Has Returned 16.4% Since SmarTrend Recommendation (LFC)
Comtex SmarTrend(R) - Fri Apr 08, 1:38PM CDT
SmarTrend identified a Downtrend for China Life Insurance (NYSE:LFC) on January 11th, 2016 at $13.85. In approximately 3 months, China Life Insurance has returned 16.39% as of today's recent price of $11.58.
LFC: 10.23 (-0.50)

Shares of LFC Down 18.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 03, 9:38AM CST
SmarTrend identified a Downtrend for China Life Insurance (NYSE:LFC) on January 11th, 2016 at $13.85. In approximately 2 months, China Life Insurance has returned 18.77% as of today's recent price of $11.25.
LFC: 10.23 (-0.50)

Global Life Hormone Industry 2014 : Market Analysis, Share, Regional Outlook, Forecast.Acute Market Reports
M2 - Thu Feb 04, 3:19AM CST
Product Synopsis
LFC: 10.23 (-0.50)

Downtrend Call Working As China Life Insurance Stock Falls 17.2% (LFC)
Comtex SmarTrend(R) - Tue Feb 02, 3:29PM CST
SmarTrend identified a Downtrend for China Life Insurance (NYSE:LFC) on January 11th, 2016 at $13.85. In approximately 3 weeks, China Life Insurance has returned 17.18% as of today's recent price of $11.47.
LFC: 10.23 (-0.50)

China Life Insurance Down 17.2% Since SmarTrend Downtrend Call (LFC)
Comtex SmarTrend(R) - Tue Feb 02, 2:17PM CST
SmarTrend identified a Downtrend for China Life Insurance (NYSE:LFC) on January 11th, 2016 at $13.85. In approximately 3 weeks, China Life Insurance has returned 17.18% as of today's recent price of $11.47.
LFC: 10.23 (-0.50)

Equities Lead Investor Sentiment - New Research on Carbo Ceramics, China Life Insurance, SK Telecom and Logitech International
ACCESSWIRE - Wed Jan 13, 7:45AM CST
NEW YORK, NY / ACCESSWIRE / January 13, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Carbo Ceramics Inc. (NYSE: CRR), China Life Insurance Co. Ltd. (NYSE: LFC), SK Telecom Co. Ltd. (NYSE: SKM) and Logitech International SA (NASDAQ: LOGI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
CRR: 13.22 (-1.19), LFC: 10.23 (-0.50), LOGI: 15.20 (-0.17), SKM: 19.94 (-0.52)

New Strong Sell Stocks for January 4th
Zacks Equity Research - Zacks Investment Research - Mon Jan 04, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
ARCX: 12.98 (+0.01), ATI: 13.44 (-0.23), LFC: 10.23 (-0.50), BP: 31.77 (-0.45), IMOS: 17.30 (-0.97)

China Life's High Premiums Earned Impress, Costs a Drag
Zacks Equity Research - Zacks Investment Research - Tue Dec 08, 1:45PM CST
We issued an updated research report on China Life Insurance Co. Ltd. (LFC) on Dec 7, 2015.
PRI: 57.17 (-0.70), AEL: 15.62 (-0.33), HIIQ: 4.55 (-0.62), LFC: 10.23 (-0.50)

BUYINS.NET: EWK, DCM, AAP, BANFP, LFC, BMRN Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Dec 03, 5:49AM CST
November 30, 2015
BMRN: 81.10 (-1.84), AAP: 153.02 (-3.76), LFC: 10.23 (-0.50), DCM: 25.73 (-0.37), BANFP: 26.79 (+0.04), EWK: 18.24 (-0.57)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading